Pathology and Pathogenesis of Chagas Heart Disease

Kevin M Bonney1, Daniel J Luthringer2, Stacey A Kim2

  • 1Liberal Studies, Faculty of Arts and Sciences, New York University, New York, NY 10003, USA;

Insights

Chagas heart disease, caused by the parasite Trypanosoma cruzi, remains unpredictable due to variable parasite virulence and host susceptibility. Further research is needed to understand its complex pathogenesis and develop predictive markers.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Parasitology

Background:

  • Chagas heart disease is an inflammatory cardiomyopathy affecting about one-third of individuals infected with the parasite Trypanosoma cruzi.
  • Transmission occurs via kissing bugs, prevalent in the Western Hemisphere, including the United States.
  • Over a century of research exists on T. cruzi epidemiology and heart disease mechanisms.

Purpose of the Study:

  • To review the pathology and pathogenesis of Chagas heart disease, the most common sequela of T. cruzi infection.
  • To highlight the challenges in predicting individual outcomes due to host-parasite variability.
  • To discuss unanswered questions and future research directions.

Main Methods:

  • Review of existing scientific literature on Chagas disease.
  • Analysis of epidemiological data and known pathogenic mechanisms.
  • Synthesis of information on myocyte destruction, inflammation, fibrosis, and edema.

Main Results:

  • Predicting individual outcomes of T. cruzi infection is currently impossible.
  • Variability in parasite virulence and human susceptibility contributes to diverse disease manifestations.
  • Multiple, interacting pathogenic mechanisms likely determine the ultimate clinical outcome.

Conclusions:

  • Chagas disease is best understood as a spectrum of related but distinct illnesses.
  • Understanding the complex interplay of factors is crucial for future therapeutic and predictive strategies.
  • Further research is essential to address key unanswered questions in Chagas heart disease.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
519
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
361
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
332
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
645
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K